NEW BRUNSWICK, N.J., Oct. 8 /PRNewswire/ -- Nominations are now being accepted for The 2009 Dr. Paul Janssen Award for Biomedical Research, which recognizes scientists in basic or clinical research who have made significant transformational contributions toward the improvement of human health. Nominations will be accepted online at http://www.pauljanssenaward.com until December 15, 2008 for evaluation by an independent Selection Committee. The winner(s) will be announced in May 2009.
Instituted in 2004, the Award includes a $100,000 cash prize to the recipient(s). Beginning in 2009, the Award will be issued annually in an ongoing celebration of the legacy of Dr. Paul Janssen. Known by colleagues throughout the scientific community as "Dr. Paul," he founded Janssen Pharmaceutica, N.V., and was one of the most productive scientists of the 20th century.
"Since its inception, this Award has recognized not only seminal scientific work, but also the core values that Dr. Paul embodied -- passion, leadership and innovation," said Paul Stoffels, M.D., who worked with Dr. Paul while at Janssen Pharmaceutica, N.V. and is now company group chairman, Research and Development, Pharmaceuticals, Johnson & Johnson. "It has been our privilege to be able to bestow this Award in Dr. Paul's memory, and we are pleased to present it annually in celebration of his work, and that of other pioneering researchers who have made a global impact on human health."
At ceremonies earlier this month, the 2008 Award was presented to
Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir
Ravinder Maini, FRCP, FMedSci, FRS of the Kennedy Institute of
Rheumatology, Imperial College London, for their role in the discovery of
tumor necrosis factor-alpha (TNF-alpha) as an effective therapeutic target
for rheumatoid arthritis and other chronic inflammatory conditions. The
2006 Award was presented to Craig
|SOURCE Johnson & Johnson|
Copyright©2008 PR Newswire.
All rights reserved